Discovery Science
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect disease risk and severity. Their research could lead to new therapies in the future.
Latest stories
Clinical Trials
June 28, 2016
Featured News
June 24, 2016
Medical Innovation
June 23, 2016
Individualized Medicine
June 22, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community